Hearing Impairment study: SEDA
Official title Evaluating a Noise Reduction Algorithm With Cochlear Implant Users
ClinicalTrials.gov ID: NCT05805384
What this study is testing
- What it's testing
- The study will check whether the algorithm improves speech understanding in different listening situations for people with cochlear implants.
- Who it's for
- Participants must have a cochlear implant and be 12 years old or older.
- What's involved
- You will use the implant with the new algorithm in various listening tests and give feedback on how well you hear speech.
- Time commitment
- The study lasts a few weeks and involves several clinic visits for testing and follow‑up.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 and older
You may be able to join if
- At least 12 years of age.
- Be post-lingually deafened cochlear implant recipients with at least 6 months experience regardless of manufacturer.
- The PI must also deem the child to be developmentally able to complete the experiments.
You likely can't join if
- Anyone who is not a cochlear implant user or is aged under 12 years.
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.